© 2015 KPMG, a Hong Kong partnership and a member firm of the KPMG network of independent member firms affiliated with KPMG International Cooperative (“KPMG International”), a Swiss entity.
All rights reserved.
A practical guide to the business review
The business review is part of the directors’
report – boards and audit committees are
responsible for ensuring that the picture of the
business is one they recognize
Other than these brief requirements in Schedule 5, there
is no further indication in the CO as to the expected
contents of the business review.
As a result, the HKICPA, at the invitation of the Companies
Registry, has issued Accounting Bulletin 5 (“AB5”) to
provide further guidance on the preparation and
presentation of the business review, following the
approach taken in the UK to this topic – more on this in the
next section of this guide.
Applicability of Schedule 5 to listed issuers
Paragraph 28 of Appendix 16 to the Main Board Listing
Rules (“App 16.28”), as amended in February 2015
2
,
requires all listed issuers, whether or not they are
incorporated in Hong Kong, to comply with Schedule 5,
consistent with the HKEx’s level playing field principle.
The HKEx has set an effective date of years ending 31
December 2015 for these amendments. Before that date,
compliance with Schedule 5 is optional for non Hong Kong
incorporated issuers, creating a short transitional period
when the requirements may differ depending on whether
the issuer is incorporated in Hong Kong or overseas.
In addition, listed issuers and other entities claiming
compliance with the disclosure requirements of the Listing
Rules, still need to ensure that the MD&A information
disclosed in the annual report includes commentary on
each of the matters specifically identified in App 16.32 (or
the equivalent GEM Rule). They may also choose to
comply with App 16.52 (or the equivalent GEM Rule)
which sets out recommended additional disclosure which
issuers are encouraged to disclose in their annual reports.
These specific MD&A items align well with the core
content elements and other matters required by Schedule
5 and therefore we expect that most issuers will include
them within the business review, rather than disclosing
them elsewhere in the annual report. In this guide we
highlight these required and recommended commentary
items in amongst the discussion of the content elements
as applicable. We have also included for easy reference
the full text of these paragraphs in Appendix 1 to this
guide, together with an index of where these items are
discussed in this guide.
Key areas of change that we encourage listed issuers
to focus on:
The impact of Schedule 5 on listed issuers will depend
on the extent to which the issuer went beyond the
minimum requirements in their MD&A’s in prior years.
However, we would encourage all listed issuers to
revisit the content and structure of their reporting to
ensure it continues to align with the information needs
of the shareholders. Areas to focus on would include:
• More rigorous descriptions of business model and
strategy to provide shareholders with an understanding
of the processes, relationships and resources that the
business depends on – and the strategy for developing
and preserving business capability over the longer
term.
• Complementing as well as supplementing the
financial statements by providing additional financial
and non-financial information which may be relevant to
the shareholders’ evaluation of past results and
assessment of future prospects.
• Improved selection and presentation of
performance measures which are relevant to an
understanding of business achievements, prospects
and capabilities.
• Better linkage within the MD&A and between the
MD&A and other elements of the report to promote
understanding and to bring together relevant
information in a cohesive way.
But the most important thing to remember is that each
business review should be unique and authentic –
shareholders will be unimpressed and skeptical at any
signs that the business review is boilerplate or
otherwise lacking in credibility.
Boards and audit committees have a particular role to
play here in ensuring that the picture of the business
presented is one that they recognize. This is
emphasized by the legal requirement that the business
review forms part of the directors’ report, whether
directly or by specific cross-reference to the MD&A
discussion within the annual report.
On 6 February 2015, the HKEx issued its Consultation Conclusions on the Review of Listing Rules on Disclosure of Financial Information with
reference to the New Companies Ordinance and Hong Kong Financial Reporting Standards and Proposed Minor/Housekeeping Rule Amendments
to update the Listing Rules for the new Companies Ordinance disclosure requirements. Amendments to the Listing Rules were included as an
appendix to the Consultation Conclusions. These amendments are mandatory for financial years ending on or after 31 December 2015. This guide is
based on these updated Listing Rules.